NEPH
NEPHROS INC
$3.57
-1.79%
$39.4M
No data for this timeframe.
Vol
Market Cap$39.4M
Cap SizeNano Cap
Inst. Holders4 funds
Inst. Value$1.7M
Inst. Activity2 buys / 0 sells
Reddit Sentiment38° Cool
SEC Reports2
Press Releases2
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001196298·Prev Close $3.63
Recent Activity
May 7, 2026
SEC
Nephros reported Q1 2026 revenue of $5.2M, up 7% YoY, but net income fell sharply to $140k from $558k due to tariff cost
8-K — Impact 5/10
May 7, 2026
earnings_calendar
NEPH Q1 2026 Earnings Scheduled — 2026-05-07
Apr 30, 2026
SEC
Nephros announced the scheduling of its Q1 2026 earnings conference call for a future date. No financial results were re
PRESS-RELEASE — Impact 2/10
Mar 23, 2026
Insider
Krandel Judy sold 68,861 shares
Chief Financial Officer @ $0.00 ($0.00)
Mar 23, 2026
Insider
Krandel Judy sold 68,861 shares
Chief Financial Officer @ $1.71 ($117.8K)
Mar 23, 2026
Insider
Banks Robert R. Jr. sold 120,000 shares
President and CEO @ $0.00 ($0.00)
Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
103,772 shares ($506.4K)
Inst.
MORGAN STANLEY — DOUBLED
17,959 shares ($87.6K)
Price Targets
Historical data — last covering-analyst action Aug 2025. No current recommendation available.
$7.00 (Aug 2025)
Current $3.57
Low $6.00
Median $7.00
High $8.00
2 analysts
$6.00
$8.00
Analyst Ratings
2Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 8, 2025 | Maxim Group | MAINTAIN | Buy → Buy |
| Nov 12, 2024 | Benchmark | REITERATE | Speculative Buy → Speculative Buy |
| May 15, 2024 | Benchmark | REITERATE | Speculative Buy → Speculative Buy |
| Mar 8, 2024 | Benchmark | UPGRADE | Hold → Speculative Buy |
| Jan 26, 2021 | B. Riley Securities | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Next Q | $0.03 | $0.02 — $0.03 | -17% YoY | 2 |
| Current FY | $0.04 ▼ -25.0% | $0.03 — $0.06 | -59% YoY | 2 |
| Next FY | $0.10 ▼ -23.1% | $0.10 — $0.10 | 122% YoY | 1 |
Latest Reports
MIXED
8-K
5/10
Nephros reported Q1 2026 revenue of $5.2M, up 7% YoY, but net income fell sharply to $140k from $558k due to tariff cost
May 7, 2026
NEUTRAL
PRESS-RELEASE
2/10
Nephros announced the scheduling of its Q1 2026 earnings conference call for a future date. No financial results were re
Apr 30, 2026
MIXED
Press
6/10
Nephros reported strong full-year 2025 financial results with revenue up 33% year-over-year to $18.8 million and net inc
Mar 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $1.1M | ADD |
| RENAISSANCE TECHNOLOGIES LLC | $506.4K | ADD |
| MORGAN STANLEY | $87.6K | DOUBLED |
| BANK OF AMERICA CORP | $356.00 | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 23, 2026 | Krandel Judy | M | $0.00 |
| Mar 23, 2026 | Krandel Judy | M | $117.8K |
| Mar 23, 2026 | Banks Robert | M | $0.00 |
| Mar 23, 2026 | Banks Robert | M | $172.8K |
| Mar 16, 2026 | Amron Arthur | A | $0.00 |
Reddit Sentiment
38°
Cool
Bearish
Neutral
Bullish
4 institutional holders with $1.7M total value (355,448 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, MORGAN. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 233,644 | $1.1M | 65.7% | ADD +58.4% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 103,772 | $506.4K | 29.2% | ADD +25.8% |
| 3 | MORGAN STANLEY | 17,959 | $87.6K | 5.1% | DOUBLED +837.8% |
| 4 | BANK OF AMERICA CORP /DE/ | 73 | $356.00 | 0.0% | ADD +54.4% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | ADD | 82,500 | 103,772 | +25.8% | $506.4K | 2025-Q4 |
| MORGAN STANLEY | DOUBLED | 1,915 | 17,959 | +837.8% | $87.6K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 10,900 | 82,500 | +656.9% | $390.2K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 2,523 | 66 | -97.4% | $312.00 | 2025-Q3 |
| VANGUARD GROUP INC | ADD | 204,158 | 323,443 | +58.4% | $1.3M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 10,900 | — | $44.6K | 2025-Q2 |
| UBS Group AG | NEW | — | 2,523 | — | $10.3K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 5,423 | 1,915 | -64.7% | $7.8K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 79 | 122 | +54.4% | $499.00 | 2025-Q2 |
| UBS Group AG | EXIT | 40,208 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 121 | 40,208 | +33129.8% | $59.1K | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 24,444 | 0 | -100.0% | $0.00 | 2024-Q4 |
3 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Krandel Judy | Chief Financial Officer | M | 68,861 | $0.00 | $0.00 |
| Mar 23, 2026 | Krandel Judy | Chief Financial Officer | M | 68,861 | $1.71 | $117.8K |
| Mar 23, 2026 | Banks Robert R. Jr. | President and CEO | M | 120,000 | $0.00 | $0.00 |
| Mar 23, 2026 | Banks Robert R. Jr. | President and CEO | M | 120,000 | $1.44 | $172.8K |
| Mar 16, 2026 | Amron Arthur H | Director | A | 3,610 | $0.00 | $0.00 |
| Mar 16, 2026 | Krandel Judy | Chief Financial Officer | A | 4,000 | $0.00 | $0.00 |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 1 neutral. Avg impact: 3.5/10.
Historical analyst distribution (last covering-analyst action Aug 2025): 88% buy across 8 analysts — 2 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Aug 2025. No current recommendation available.
$7.00 mean target (Aug 2025)
$6.00 Low
$8.00 High
| Metric | Value |
|---|---|
| Current Price | $3.57 |
| Target Low | $6.00 |
| Target Mean | $7.00 |
| Target Median | $7.00 |
| Target High | $8.00 |
| # Analysts | 2 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $-0.01 | $0.01 | -100.0% | — | 0↑ 1↓ | $0.0B | 14.3% | 2 |
| Next Q 2026-09-30 |
$0.03 | $0.02 | $0.03 | -16.7% | +0.0% | 0↑ 1↓ | $0.0B | 13.5% | 2 |
| Current FY 2026-12-31 |
$0.04 | $0.03 | $0.06 | -59.1% | -25.0% | 0↑ 1↓ | $0.0B | 12.2% | 2 |
| Next FY 2027-12-31 |
$0.10 | $0.10 | $0.10 | 122.2% | -23.1% | 0↑ 1↓ | $0.0B | 9.7% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.000 | |
| 7d ago | $-0.010 | +0.010 |
| 30d ago | $0.000 | |
| 60d ago | $0.000 | |
| 90d ago | $0.020 | -0.020 |
3 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 3 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Aug 8, 2025 | Maxim Group | MAINTAIN | Buy | Buy |
| Nov 12, 2024 | Benchmark | REITERATE | Speculative Buy | Speculative Buy |
| May 15, 2024 | Benchmark | REITERATE | Speculative Buy | Speculative Buy |
| Mar 8, 2024 | Benchmark | UPGRADE | Hold | Speculative Buy |
| Jan 26, 2021 | B. Riley Securities | INITIATE | — | Buy |
| Oct 24, 2019 | Benchmark | INITIATE | — | Speculative Buy |
| Oct 4, 2019 | Maxim Group | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Apr 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Mar 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
38°
Cool
Bearish
Neutral
Bullish
4 mentions
0 bullish
2 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Mar 24, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
| Mar 24, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
| Mar 24, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 24, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Recent Reddit Threads
I need advice about NEPH
▲ 1
💬 1
⚡ 0.5
Advice about NEPH
▲ 1
💬 0
⚡ 0.5
May 7, 2026
earnings_calendar
NEPH Q1 2026 Earnings Scheduled — 2026-05-07
Apr 30, 2026
earnings
Nephros Schedules First Quarter 2026 Financial Results Conference Call
Nephros Schedules First Quarter 2026 Financial Results Conference Call
Apr 16, 2026
other
Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership
Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership
Apr 1, 2026
other
Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
Mar 12, 2026
earnings
Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results
Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results
Mar 12, 2026
earnings_calendar
NEPH Q4 2025 Earnings After Market Close — 2026-03-12
Mar 5, 2026
earnings
Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call
Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call
Mar 5, 2026
earnings_calendar
NEPH Q4 2025 Earnings After Market Close — 2026-03-05
Mar 4, 2026
earnings_calendar
NEPH Q4 2025 Earnings After Market Close — 2026-03-04